After his grandmother’s sudden heart attack, Max was determined to find a better way to identify early stages of heart disease. As a result, Max launched his company, Heartstrings, an accurate, non-invasive and low-cost tool based on proprietary artificial intelligence technology for screening and early diagnosis of heart disease. Heartstrings’ breakthrough technology has been tested successfully and validated with more than 700 patients through two clinical trials. His vision for Heartstrings is to save at least 1 million lives each year over the next three years.
2018, Europe, Global Finalist, Winners
2nd Runner Up